Cutting-edge interdisciplinary efforts are leveraging AI to elucidate and treat neurological disorders. Digital speech biomarker studies quantify levodopa response variability in Parkinson’s disease. Novel machine learning models predict early liver metastasis in pancreatic cancer and improve Parkinson’s trial accuracy. Brain stimulation approaches enhance math learning by modulating neural connectivity. Additionally, autonomous AI-driven labs are accelerating enzyme performance improvements. These multidisciplinary innovations herald a new era integrating computation with neurological and cognitive health management.